HEALTHSPANStart secure intakeCLINICAL EVIDENCE INDEXUPDATED 09 / 2026
Human outcomes and guideline-supported uses come first, with direct links to the research behind every IVLV Healthspan offering.
4 offerings indexed
Guidelines support testosterone therapy only for men with compatible symptoms and consistently low testosterone confirmed by appropriate testing.
MonitoringFollow-up combines how you feel with repeat testosterone, hematocrit, and other targeted measures so the plan can be refined over time.
Randomized trials in selected men with secondary hypogonadism found increased testosterone while sperm concentration was preserved compared with topical testosterone.
MonitoringFollow-up tracks symptoms, hormone levels, fertility goals, and response so dose and timing can be refined.
Sildenafil and tadalafil are established PDE5-inhibitor treatments for erectile dysfunction when prescribed in standard oral formulations to appropriate patients.
MonitoringYour physician matches the medication and schedule to your cardiovascular health, current medications, desired timing, and response.
Sildenafil and tadalafil are established treatments for erectile dysfunction. Customized dissolving-tablet formulas with oxytocin offer another route for an individualized plan.
MonitoringYour physician selects the combination and schedule using your health history, current medications, preferred timing, and response.
3 offerings indexed
The randomized trial linked here studied once-weekly injectable tirzepatide and found substantial weight loss in eligible adults alongside lifestyle changes. It did not study the dissolving tablet shown here. Your physician decides whether that option is appropriate for you.
MonitoringIf prescribed, follow-up may include weight, appetite, side effects, and metabolic measures. Tests are ordered only when they help guide or safely monitor treatment.
The randomized trial linked here studied once-weekly injectable semaglutide 2.4 mg and found substantial weight loss in eligible adults alongside lifestyle changes. It did not study the compounded dissolving tablet shown here. Your physician decides whether that option is appropriate for you.
MonitoringIf prescribed, follow-up may include weight, appetite, side effects, and metabolic measures. Tests are ordered only when they help guide or safely monitor treatment.
Evidence and regulatory status differ by medication and indication. Metformin may be considered off label in selected metabolic contexts; naltrexone alone is not an FDA-approved obesity treatment.
MonitoringYour physician first decides whether an oral medicine is appropriate. If prescribed, follow-up focuses on side effects, weight, and whether the medicine is helping; tests are ordered only when relevant.
3 offerings indexed
Topical minoxidil has randomized-trial evidence for androgenetic alopecia and is an established treatment option.
MonitoringThe physician confirms the hair-loss pattern, establishes baseline photographs, and follows density, coverage, and scalp comfort over time.
Topical minoxidil and topical finasteride each have human trial data for androgenetic alopecia, including a phase III topical-finasteride study.
MonitoringBaseline photographs and follow-up visits track density, coverage, scalp comfort, and response over several months so the formula can be refined.
A small randomized human study of a topical complex containing GHK peptide reported improved hair-count measures over six months. Healthspan uses that research as background for an individualized GHK-Cu scalp plan.
MonitoringBaseline photographs and follow-up track coverage, density, scalp comfort, and visible response over time.
PRIMARY SOURCES → PERSONAL PLANNEXT STEP
Bring your goals and questions to a private physician evaluation. Your physician decides whether medication is appropriate and, if so, which option and follow-up plan make sense for you.